Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 482,000 shares at $62.56 ($31.1M) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Open-market sale of $31.1M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.56 | 35,182 | $2.2M | 7.1% |
| 2 | $62.56 | 35,182 | $2.2M | 7.1% |
| 3 | $63.57 | 31,948 | $2.0M | 6.5% |
| 4 | $63.57 | 31,948 | $2.0M | 6.5% |
| 5 | $64.67 | 104,544 | $6.8M | 21.8% |
| 6 | $64.67 | 104,544 |
| $6.8M |
| 21.8% |
| 7 | $65.47 | 61,412 | $4.0M | 12.9% |
| 8 | $65.47 | 61,412 | $4.0M | 12.9% |
| 9 | $66.43 | 5,677 | $377K | 1.2% |
| 10 | $66.43 | 5,677 | $377K | 1.2% |
| 11 | $67.32 | 2,237 | $151K | 0.5% |
| 12 | $67.32 | 2,237 | $151K | 0.5% |
| Total | $64.49 avg | 482,000 | $31.1M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |